324 related articles for article (PubMed ID: 19264688)
1. Clinical practice. Graves' ophthalmopathy.
Bartalena L; Tanda ML
N Engl J Med; 2009 Mar; 360(10):994-1001. PubMed ID: 19264688
[No Abstract] [Full Text] [Related]
2. Graves' disease: clinical pathophysiology, presentation and treatment options.
Holt K
J Pract Nurs; 2010; 60(3):13-8. PubMed ID: 21175104
[No Abstract] [Full Text] [Related]
3. Do glucocorticoids affect outcome in Graves' disease following radioiodine therapy?
Salvatore D; Fenzi G
Nat Clin Pract Endocrinol Metab; 2006 Apr; 2(4):194-5. PubMed ID: 16932282
[No Abstract] [Full Text] [Related]
4. [Management of Graves' orbitopathy: evidence-based recommendations].
Ponto KA; Pitz S; Mann WJ; Weber MM; Pfeiffer N; Kahaly GJ
Dtsch Med Wochenschr; 2009 Dec; 134(49):2521-4. PubMed ID: 19941237
[TBL] [Abstract][Full Text] [Related]
5. Optimal management of Graves orbitopathy: a multidisciplinary approach.
Soeters MR; van Zeijl CJ; Boelen A; Kloos R; Saeed P; Vriesendorp TM; Mourits MP
Neth J Med; 2011; 69(7):302-8. PubMed ID: 21934174
[TBL] [Abstract][Full Text] [Related]
6. Endocrine ophthalmopathy and radioiodine therapy.
Karlsson FA
Acta Oncol; 2006; 45(8):1046-50. PubMed ID: 17118837
[TBL] [Abstract][Full Text] [Related]
7. Graves' Disease.
Smith TJ; Hegedüs L
N Engl J Med; 2016 Oct; 375(16):1552-1565. PubMed ID: 27797318
[No Abstract] [Full Text] [Related]
8. Relation between therapy for hyperthyroidism and the course of Graves' ophthalmopathy.
Bartalena L; Marcocci C; Bogazzi F; Manetti L; Tanda ML; Dell'Unto E; Bruno-Bossio G; Nardi M; Bartolomei MP; Lepri A; Rossi G; Martino E; Pinchera A
N Engl J Med; 1998 Jan; 338(2):73-8. PubMed ID: 9420337
[TBL] [Abstract][Full Text] [Related]
9. Occurrence of ophthalmopathy after treatment for Graves' hyperthyroidism. The Thyroid Study Group.
Tallstedt L; Lundell G; Tørring O; Wallin G; Ljunggren JG; Blomgren H; Taube A
N Engl J Med; 1992 Jun; 326(26):1733-8. PubMed ID: 1489388
[TBL] [Abstract][Full Text] [Related]
10. [Graves' ophthalmopathy].
Hiromatsu Y
Nihon Rinsho; 2006 May; Suppl 1():307-10. PubMed ID: 16776151
[No Abstract] [Full Text] [Related]
11. Graves' disease and thyroid associated ophthalmopathy following radioiodine therapy in euthyroid multinodular goiter.
Munigoti S; Samat A; Keston Jones M
Thyroid; 2008 May; 18(5):585. PubMed ID: 18466082
[No Abstract] [Full Text] [Related]
12. Graves' ophthalmopathy and dermopathy. Preface.
Wiersinga WM
Best Pract Res Clin Endocrinol Metab; 2012 Jun; 26(3):227. PubMed ID: 22632360
[No Abstract] [Full Text] [Related]
13. Management of Graves' ophthalmopathy.
Wiersinga WM
Nat Clin Pract Endocrinol Metab; 2007 May; 3(5):396-404. PubMed ID: 17452966
[TBL] [Abstract][Full Text] [Related]
14. [Graves' orbitopathy].
Balázs C
Orv Hetil; 2006 Jun; 147(22):1011-7. PubMed ID: 16913090
[TBL] [Abstract][Full Text] [Related]
15. Practical Guidelines Management of Graves Ophthalmopathy.
Subekti I; Soewondo P; Soebardi S; Darmowidjojo B; Harbuwono DS; Purnamasari D; Tarigan TJE; Wisnu W; Tahapary DL; Kurniawan F; Sidik M; Nusanti S; Dewiputri S; Suharko H; Suardana GG; Suroyo I; Wulani V; Siswoyo AD; Gondhowiardjo S; Kodrat H
Acta Med Indones; 2019 Oct; 51(4):364-371. PubMed ID: 32041923
[TBL] [Abstract][Full Text] [Related]
16. [Corticosteroids and radiotherapy in the treatment of Graves' ophthalmopathy].
Nasr E; Khater S; Nehme-Nasr D; Azoury F; Jambart S
J Med Liban; 2010; 58(2):86-90. PubMed ID: 20549894
[TBL] [Abstract][Full Text] [Related]
17. Radioiodine therapy of Graves' hyperthyroidism in patients without pre-existing ophthalmopathy: can glucocorticoids prevent the development of new ophthalmopathy?
Dederichs B; Dietlein M; Jenniches-Kloth B; Schmidt M; Theissen P; Moka D; Schicha H
Exp Clin Endocrinol Diabetes; 2006 Jul; 114(7):366-70. PubMed ID: 16915539
[TBL] [Abstract][Full Text] [Related]
18. Management plan and delivery of care in Graves' ophthalmopathy patients.
Yang M; Perros P
Best Pract Res Clin Endocrinol Metab; 2012 Jun; 26(3):303-11. PubMed ID: 22632367
[TBL] [Abstract][Full Text] [Related]
19. Glucocorticoid therapy of Graves' ophthalmopathy.
Bartalena L; Marocci C; Bogazzi F; Bruno-Bossio G; Pinchera A
Exp Clin Endocrinol; 1991 May; 97(2-3):320-7. PubMed ID: 1915650
[No Abstract] [Full Text] [Related]
20. Treatment of Graves' ophthalmopathy.
González-García A; Sales-Sanz M
Med Clin (Barc); 2021 Feb; 156(4):180-186. PubMed ID: 33069387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
